Equities

AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NZD)2.84
  • Today's Change0.00 / 0.00%
  • Shares traded18.14k
  • 1 Year change-16.47%
  • Beta0.6138
Data delayed at least 20 minutes, as of May 17 2024 02:51 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 09-May-24
Select bar for recommendation details.
Recommendations09-May-24
Buy0
Outperform1
Hold0
Underperform1
Sell0

Share price forecast in NZD

The 2 analysts offering 12 month price targets for AFT Pharmaceuticals Ltd have a median target of 3.70, with a high estimate of 4.60 and a low estimate of 2.80. The median estimate represents a 30.28% increase from the last price of 2.84.
High62.0%4.60
Med30.3%3.70
Low-1.4%2.80

Dividends

Historical dividend information is not available for AFT Pharmaceuticals Ltd.
Div growth (TTM)--
More ▼

Earnings history & estimates in NZD

AFT Pharmaceuticals Ltd reported annual 2023 earnings of 0.10 per share on May 21, 2023.
Average growth rate+83.29%
More ▼

Revenue history & estimates in NZD

AFT Pharmaceuticals Limited had revenues for the full year 2023 of 156.64m. This was 20.20% above the prior year's results.
Average growth rate+16.64%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.